Breast Biopsy Market Covid-19 Impact Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, And Growth Forecast To 2033
-
24572
-
March 2023
-
180
-
-
This report was compiled by Trishita Deb Trishita Deb is an experienced market research and consulting professional with over 7 years of expertise across healthcare, consumer goods, and materials, contributing to over 400 healthcare-related reports. Correspondence Team Lead- Healthcare Linkedin | Detailed Market research Methodology Our methodology involves a mix of primary research, including interviews with leading mental health experts, and secondary research from reputable medical journals and databases. View Detailed Methodology Page
-
Impacts of the COVID-19 Pandemic:
Most industries across the world have been negatively impacted over the last 18 months. This can be attributed to significant disruptions experienced by their respective manufacturing and supply-chain operations as a result of various precautionary lockdowns, as well as other restrictions that were enforced by governing authorities across the globe. The same applies to the global Breast Biopsy market. Moreover, consumer demand has also subsequently reduced as individuals are now more keen on eliminating non-essential expenses from their respective budgets as the general economic status of most individuals have been severely affected by this outbreak. These aforementioned elements are expected to burden the revenue trajectory of the global Breast Biopsy market over the forecast timeline. However, as respective governing authorities begin to lift these enforced lockdowns, the global Breast Biopsy market is expected to recover accordingly.
A breast biopsy is a medical procedure that involves removing a small sample of tissue expander from the breast for examination under a microscope. The tissue sample is taken to check for the presence of breast cancer or other abnormal cells. There are several different types of breast biopsy procedures. Fine-needle aspiration (FNA) biopsy is thin, hollow needle is inserted into the breast to remove a small sample of cells. Core needle biopsy is slightly larger needle is used to remove a small cylinder of tissue ("core") from the breast. Surgical biopsy is surgical incision is made in the breast to remove larger sample of tissue. specialized x-ray machine is used to guide a needle to the area of concern, then small sample of tissue is removed. Specialized ultrasound machine is used to guide needle to the area of concern, then small sample of tissue is removed.
The type of biopsy that is used depends on the size, location and characteristics of the lump or suspicious area. A biopsy is usually done in the hospital, usually an outpatient procedure, and it usually performed under local anesthesia with or without sedation.What will the market valuation of the global Breast Biopsy industry be in 2021?
The Breast Biopsy market is expected to index a valuation of USD 4.9 Billion from a value of USD 3.1 Billion registered in 2023. Over the course of this forecast timeline, the global Breast Biopsy market is slated to index a CAGR of 5.9%.
Key Market Segments
Type
- On the basis of type
- the global market is divided into :
- Open surgical breast biopsy - excisional breast biopsy and incisional breast biopsy.
- Needle breast biopsy - core-needle biopsy
- fine-needle aspiration
- biopsy and vacuum-assisted biopsy.
product
- biopsy tables
- biopsy needles
- localization wires
- guidance systems and others
- which include punches
- markers and sutures.
guidance
- magnetic resonance-guided breast biopsy
- ultrasound-guided breast biopsy
- mammography-guided stereotactic breast biopsy
List Major Industry Players That Are Covered in the Breast Biopsy Report?
As a means of boosting global prominence, businesses encompassed in the Breast Biopsy sector are now more engaged with initiating approaches such as targeted marketing, CSR programs, etc. A significantly noticeable trend that is being observed across the board is that these companies now aim to manage a given business-related activity in a country that provides favorable policies. In doing so, it enables these given businesses to lower costs, while employing industry specialists for every critical juncture of their respective organization. Authorities in emerging countries such as India, China, Taiwan, and Indonesia, etc., are enacting policies to attract foreign investors to the respective manufacturing sectors by lowering trade tariffs and duties in order to generate more jobs. This report analyzes the Breast Biopsy market in a comprehensive manner, outlining its competitive landscape, possible growth opportunities and potential pitfalls, offering information on numerous market players, including:
- Cardinal Health Inc.
- Angiotech
- Galini SRL
- Carefusion Corp. Cook Medical Incorporated
- Ethicon Endo-Surgery
- Dickinson Company
- Argon Medical Devices Becto
- Hologic Inc.
- UK Biopsy
- Biomed Diagnostics Inc.
- DTR Medical
- F. Hoffmann-La Roche Ltd.
- Bard Peripheral Vascular Inc.
- Mammotome
- Intact Medical
- Laboratory Corporation of America Holdings
- OncoCyte Corporation.
Furthermore, several key market players of the global Breast Biopsy sector are now more focused on setting-up effective joint ventures, acquisitions, and/or collaborations in order to expand their respective consumer bases. By doing so, they stand to boost their given target bases by being able to cater to them on both a global as well as domestic level. This element in conjunction with favorable prospects emerging from developing nations from the Asia-Pacific region such as India, China, Taiwan, Indonesia, etc., are anticipated to create a surge in business prospects for concerned players over the course of this forecast period.
What are the Key Regions of Operation for the Breast Biopsy Market?
The key areas of operation for the global Breast Biopsy market are:
- North America
- Europe
- Asia Pacific
- Latin America
- MEA
Key Factors Covered in the Breast Biopsy Market Report:
- A comprehensive overview of the global Breast Biopsy market
- Detailed information on factors that will fuel or hamper market growth prospects for the global Breast Biopsy market
- Potential market CAGR projections over the forecast period
- Precise market size estimations of the Breast Biopsy industry
- Accurate upcoming trends and consumer behavior pattern predictions
- Potential expansion prospects for the Breast Biopsy market
- A thorough analysis of the Breast Biopsy market?s competitive landscape
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn *NOTE - All statements of fact, opinion, or analysis expressed in any reports published, are those of concerned analysts. They do not necessarily reflect any formal position or view of Marketresearch.Biz.
-
-
- Cardinal Health Inc.
- Angiotech
- Galini SRL
- Carefusion Corp. Cook Medical Incorporated
- Ethicon Endo-Surgery
- Dickinson Company
- Argon Medical Devices Becto
- Hologic Inc.
- UK Biopsy
- Biomed Diagnostics Inc.
- DTR Medical
- F. Hoffmann-La Roche Ltd.
- Bard Peripheral Vascular Inc.
- Mammotome
- Intact Medical
- Laboratory Corporation of America Holdings
- OncoCyte Corporation.